“New” Antigenic Targets and Methodological Approaches for Refining Laboratory Diagnosis of Antiphospholipid Syndrome

Misasi, Roberta; Capozzi, Antonella; Longo, Agostina; Recalchi, Serena; Lococo, Emanuela; Alessandri, Cristiano; Conti, Fabrizio; Valesini, Guido; Sorice, Maurizio
March 2015
Journal of Immunology Research;3/19/2015, Vol. 2015, p1
Academic Journal
Antiphospholipid antibodies (aPLs) are a heterogeneous group of antibodies directed against phospholipids or protein/phospholipid complexes. Currently, aPLs are assessed using either “solid-phase” assays that identify anticardiolipin antibodies and anti-β2-glycoprotein I antibodies or “liquid-phase” assay that identifies lupus anticoagulant. However, in the last few years, “new” antigenic targets and methodological approaches have been employed for refining laboratory diagnosis of antiphospholipid syndrome (APS). In this review the potential diagnostic value of antibodies to domains of β2-GPI, prothrombin/phosphatidylserine, vimentin/cardiolipin, protein S, protein C, annexin A2, annexin A5, and phospholipid antigens is discussed. Moreover, new technical approaches, including chemiluminescence, multiline dot assay, and thin layer chromatography (TLC) immunostaining, which utilize different supports for detection of aPL, have been developed. A special focus has been dedicated on “seronegative” APS, that is, those patients with a clinical profile suggestive of APS (thromboses, recurrent miscarriages, or foetal loss), who are persistently negative for the routinely used aPL. Recent findings suggest that, in sera from patients with SN-APS, antibodies may be detected using “new” antigenic targets (mainly vimentin/cardiolipin) or methodological approaches different from traditional techniques (TLC immunostaining). Thus, APS represents a mosaic, in which antibodies against different antigenic targets may be detected thanks to the continuously evolving new technologies.


Related Articles

  • Antiphospholipid scoring: significance in diagnosis and prognosis. Oku, K; Amengual, O; Atsumi, T // Lupus;Oct2014, Vol. 23 Issue 12, p1269 

    Recently our group introduced the “antiphospholipid score” (aPL-S), a quantitative marker that represents aPL profile. We have validated its efficacy for the diagnosis of antiphospholipid syndrome (APS) and predictive value for thrombosis. The study comprised two independent sets of...

  • Antiphospholipid antibodies in localized scleroderma: the potential role of screening tests for the detection of antiphospholipid syndrome. Lis-Święty, Anna; Brzezińska-Wcisło, Ligia; Arasiewicz, Hubert; Bergler-Czop, Beata // Advances in Dermatology & Allergology / Postepy Dermatologii i A;Apr2014, Vol. 31 Issue 2, p65 

    Introduction: The presence of antiphospholipid antibodies (aPL) is associated with infections, drugs and autoimmune disorders. Those antibodies are also detected in approximately 5-20% of the healthy population. The presence of aPL can lead to the occurrence of thrombotic events or abortion,...

  • Kikuchi’s lymphadenopathy: a relatively rare but important cause of lymphadenopathy in Greece, potentially associated with the antiphospholipid syndrome. Vassilakopoulos, Theodoros P.; Pangalis, Gerassimos A.; Siakantaris, Marina P.; Levidou, Georgia; Yiakoumis, Xanthi; Floudas, Charalambos; Gribabis, Despina; Bouros, Spyridon; Metaxas, Ioannis; Dimitriadou, Evangelia M.; Pantazi, Lambrini; Tsoukala, Catherine; Korkolopoulou, Penelope; Andreopoulos, Anastasios; Vaiopoulos, George // Rheumatology International;May2010, Vol. 30 Issue 7, p925 

    Kikuchi-Fujimoto disease is a form of reactive lymphadenopathy, which was firstly described in Japan, but is uncommon in the Western world. We retrospectively reviewed the medical records of nine cases of adult or adolescent Kikuchi’s disease diagnosed in a single Haematology Unit in...

  • Hughes' syndrome. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p388 

    An encyclopedia entry for the term "Hughes' syndrome" is presented. Also known as antiphospholipid syndrome, Hughes' syndrome is characterized by an increased tendency for the blood to clot inside the blood vessels. Particular focus is given to its etiology. Symptoms associated with a blood clot...

  • Laboratory Criteria of Antiphospholipid Syndrome Need to be Updated or Strictly Followed? Martinuzzo, Marta // Open Autoimmunity Journal;2010 Special Issue 1, p28 

    The antiphospholipid syndrome is a very relevant disease that implicates different clinical features and laboratory criteria. Regarding laboratory diagnosis, it has been established in the last consensus that tests included are lupus anticoagulant (LA), anti cardiolipin (aCL) and anti β2...

  • Antiphospholipid (Hughes) syndrome: a review with update.  // Journal of Cutaneous Medicine & Surgery;Sep/Oct2004, Vol. 8 Issue 5, p371 

    Discusses the abstract of the study "Antiphospholipid (Hughes) Syndrome: A Review With Update," by A.N. Malaviya.

  • Migraine, memory loss, and 'multiple sclerosis.' Neurological features of the antiphospholipid (Hughes') syndrome. Hughes, G.R.V. // Postgraduate Medical Journal;Feb2003, Vol. 79 Issue 928, p81 

    Describes the neurological features of the antiphospholipid syndrome, or Hughes' syndrome. Headache and migraine; Memory loss; Epileptic seizures; Stroke; Myelopathy; Multiple sclerosis; Chorea; Neuropathy; Behavioral disorders; Treatment; Research and speculation.

  • Relationship Between Antiprothrombin Antibodies and Pregnancy Loss.  // Fertility Weekly;3/31/2003, p7 

    Examines the relationship between antiprothrombin antibodies (AA) and pregnancy loss. Association of the immunoglobulin G AA with early pregnancy loss; Recommendation of routine testing for AA in young female patients with antiphospholipid syndrome (APS); Description of APS as a multisystemic...

  • Increased Performances of the Biological Diagnosis of the Antiphospholipid Syndrome by the Use of a Multiplex Assay. Sénant, M.; Rostane, H.; Fernani-Oukil, F.; Hosking, F.; Bellery, F.; Courchinoux, A.; Tartour, E.; Darnige, L.; Dragon-Durey, M-A. // Journal of Immunology Research;5/6/2015, Vol. 2015, p1 

    Antiphospholipid syndrome (APS) is characterized by development of venous and/or arterial thrombosis and pregnancy morbidity. Biological criteria are the persistent presence of lupus anticoagulant (LA) and/or anti-cardiolipin (aCL) and/or anti-B2GP1 autoantibodies’ positivity. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics